Osteopenia, a condition characterized by lower-than-normal bone mineral density, affects an estimated 40% of adults worldwide. It is particularly common among older adults and postmenopausal women, yet many people are unaware they have it because the condition rarely causes noticeable symptoms.
Often, osteopenia is discovered only after a fracture occurs. In the United Kingdom alone, reduced bone density contributes to more than 500,000 fractures each year, placing a substantial burden on both individuals and healthcare systems.
How Bone Loss Develops
Bone is living tissue that is continuously renewed through a process known as bone remodeling.
During this process, old bone is broken down while new bone is formed. In younger adults, these two processes are generally balanced, allowing bone density to remain stable.
Peak bone mass is typically reached between the mid-20s and early 30s.
After this point, bone breakdown gradually begins to exceed bone formation, resulting in a slow decline in bone density that may eventually become clinically significant.
Although aging is the strongest risk factor for bone loss, hormonal changes also play an important role.
The sharp decline in estrogen levels after menopause accelerates bone breakdown, helping explain why approximately one in two women over the age of 50 will experience a fragility fracture during their lifetime.
Lifestyle and Medical Risk Factors
Several lifestyle habits can accelerate bone loss and increase fracture risk.
Smoking, excessive alcohol consumption, and long-term physical inactivity all weaken bone strength while also increasing the likelihood of falls.
Nutrition is another major factor.
Insufficient calcium intake and low vitamin D levels limit the body’s ability to build and maintain healthy bones, and both deficiencies are common in many populations.
Certain medical conditions can also contribute to osteopenia.
Inflammatory bowel diseases such as Crohn’s disease, as well as celiac disease, may interfere with nutrient absorption. Long-term corticosteroid use and hormone-related disorders such as hyperthyroidism are also associated with increased bone loss and fracture risk.
How Osteopenia Is Diagnosed
Identifying osteopenia before fractures occur allows healthcare professionals to intervene early.
The standard test is a dual-energy X-ray absorptiometry (DXA) scan, which measures bone mineral density using a low-dose X-ray.
Results are reported as a T-score that compares a person’s bone density with that of a healthy young adult.
A T-score between −1.0 and −2.5 indicates osteopenia, while a score below −2.5 is consistent with osteoporosis.
Doctors also frequently use fracture risk calculators that combine bone density measurements with factors such as age, sex, medication use, and medical history.
These tools estimate a person’s likelihood of experiencing a major fracture over the next 10 years and help determine whether medication may be appropriate.
Slowing Bone Loss and Preventing Fractures
The primary goals of osteopenia management are to slow further bone loss and reduce the risk of fractures.
Lifestyle interventions form the foundation of treatment and may be combined with medication for people at higher risk.
Weight-bearing activities, including brisk walking, jogging, and dancing, stimulate bone formation by placing controlled stress on the skeleton.
Resistance training strengthens muscles, providing additional support for bones and improving joint stability.
Exercises such as Tai Chi can improve balance, coordination, and lower-body strength.
By reducing the risk of falls, these activities also help lower the likelihood of fractures in people with reduced bone density.
Nutrition is equally important.
Adequate calcium intake helps maintain bone structure, while vitamin D is essential for efficient calcium absorption and healthy bone metabolism.
Good dietary sources of calcium include dairy products, leafy green vegetables, nuts, and calcium-fortified foods.
In countries with limited winter sunlight, including the United Kingdom, vitamin D supplementation is often recommended, particularly for older adults and individuals who spend little time outdoors.
When Medication May Be Recommended
Not everyone diagnosed with osteopenia requires prescription medication.
Treatment decisions are usually based on an individual’s overall fracture risk, previous fragility fractures, and other underlying medical conditions.
For people at higher risk, physicians may prescribe antiresorptive medications that slow bone breakdown and help maintain or improve bone mineral density.
Although these medications are primarily used to treat osteoporosis, they may also benefit selected patients with osteopenia who have an elevated risk of fractures.
Other therapies, including hormone-related treatments or medications that stimulate new bone formation, may be appropriate in specific circumstances.
As with any long-term treatment, potential benefits must be weighed against possible side effects, and therapy should be reviewed regularly as health needs change over time.
An Opportunity for Prevention
Experts emphasize that osteopenia should not be viewed as an inevitable step toward osteoporosis.
Instead, it serves as an early warning sign that offers an opportunity to take preventive action before serious bone damage occurs.
Although progression to osteoporosis is common, it is not inevitable.
Research indicates that early diagnosis, regular weight-bearing exercise, resistance training, a balanced diet rich in calcium and vitamin D, smoking cessation, and limiting alcohol intake can slow bone loss and, in some cases, produce modest improvements in bone density.
Bone health is shaped by lifelong habits and cumulative exposures beginning in childhood.
Building healthy behaviors early and maintaining them throughout adulthood remains one of the most effective ways to preserve bone strength and reduce the risk of disabling fractures later in life.
